Clinical Trial Update: Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial of solithromycin in adolescents and children with community-acquired bacterial pneumonia has terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Bacterial Pneumonia

Drugs mentioned

• Solithromycin (solithromycin)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Community-acquired Bacterial Pneumonia | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2019-01-03